LIGHT, a member of the TNF superfamily, induces morphological changes and delays proliferation in the human rhabdomyosarcoma cell line RD

被引:21
作者
Hikichi, Y
Matsui, H
Tsuji, I
Nishi, K
Yamada, T
Shintani, Y
Onda, H
机构
[1] Takeda Chem Ind Ltd, Div Pharmaceut Res, Discovery Res Labs 1, Tsukuba, Ibaraki 3004293, Japan
[2] Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmaceut Discovery Ctr, Yodogawa Ku, Osaka 5328686, Japan
关键词
LIGHT; RMS; RD; cell growth; differentiation; smooth muscle alpha-actin; TPA; LT beta R;
D O I
10.1006/bbrc.2001.6039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LIGHT is a member of the tumor necrosis factor (TNF) superfamily, which binds two known receptors, lymphotoxin-beta receptor (LT betaR) and the herpesvirus entry mediator (HVEM)/TR2. We investigated the effects of LIGHT on the human rhabdmyosarcoma cell line RD. LIGHT delayed cell proliferation and induced morphological changes of the cells. These effects were not shown by other TNT family ligands such as TNF alpha and LT alpha, which induced the transcriptional activity of nuclear factor-kappaB (NF-kappaB) and NF-kappaB-responsible chemokine productions in the same manner as did LIGHT. LT alpha1 beta2, another TNF family ligand for LT betaR, was shown to have similar activities in RD cells as LIGHT. Both LIGHT and LT alpha1 beta2 induced the expression of muscle-specific genes such as smooth muscle (SM) alpha -actin, while TNF alpha and LT alpha did not. These findings indicate that LIGHT may be a novel inducer of RD cell differentiation associated with SM alpha -actin expression through the LT betaR. (C) 2001 Elsevier Science.
引用
收藏
页码:670 / 677
页数:8
相关论文
共 26 条
[1]  
Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93
[2]  
AGUANNO S, 1990, CANCER RES, V50, P3377
[3]  
Baker SJ, 1996, ONCOGENE, V12, P1
[4]   TPA-INDUCED DIFFERENTIATION OF HUMAN RHABDOMYOSARCOMA CELLS - EXPRESSION OF THE MYOGENIC REGULATORY FACTORS [J].
BOUCHE, M ;
SENNI, MI ;
GROSSI, AM ;
ZAPPELLI, F ;
POLIMENI, M ;
ARNOLD, HH ;
COSSU, G ;
MOLINARO, M .
EXPERIMENTAL CELL RESEARCH, 1993, 208 (01) :209-217
[5]   ARA-C TREATMENT LEADS TO DIFFERENTIATION AND REVERSES THE TRANSFORMED PHENOTYPE IN A HUMAN RHABDOMYOSARCOMA CELL-LINE [J].
CROUCH, GD ;
KALEBIC, T ;
TSOKOS, M ;
HELMAN, LJ .
EXPERIMENTAL CELL RESEARCH, 1993, 204 (02) :210-216
[6]   A Lymphotoxin-β-Specific Receptor [J].
Crowe, Paul D. ;
VanArsdale, Todd L. ;
Walter, Barbara N. ;
Ware, Carl F. ;
Hession, Catherine ;
Ehrenfels, Barbara ;
Browning, Jeffrey L. ;
Din, Wenie S. ;
Goodwin, Raymond G. ;
Smith, Craig A. .
JOURNAL OF IMMUNOLOGY, 2014, 192 (05) :2015-2018
[7]  
DegliEsposti MA, 1997, J IMMUNOL, V158, P1756
[8]  
ELBADRY OM, 1990, CELL GROWTH DIFFER, V1, P325
[9]   Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein [J].
Ettinger, R ;
Browning, JL ;
Michie, SA ;
vanEwijk, W ;
McDevitt, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (23) :13102-13107
[10]   TPA-INDUCED DIFFERENTIATION OF HUMAN RHABDOMYOSARCOMA CELLS INVOLVES DEPHOSPHORYLATION AND NUCLEAR ACCUMULATION OF MUTANT P53 [J].
GERMANI, A ;
FUSCO, C ;
MARTINOTTI, S ;
MUSARO, A ;
MOLINARO, M ;
ZANI, BM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 202 (01) :17-24